Manufacturing risk assessment and uncertainty analysis for early stage (Pre-phase III) pharmaceutical drug production
Author(s)Chen, Emily, M. Eng. Massachusetts Institute of Technology
Massachusetts Institute of Technology. Supply Chain Management Program.
MetadataShow full item record
Supply chains in the pharmaceutical industry are growing increasingly more complex and expanding their geographic reach both in manufacturing production and to the end consumer, the patient. Physical development, manufacturing and distribution of these drugs, both of biologics and small molecules, is extremely technical in science and processes. Additionally, the industry is highly regulated with nuanced requirements that vary by country of origin and consumption, adding complexity to the drug development process. For these reasons, companies are pushing for longer range planning and forecasting of their drug pipelines, beginning the process earlier for drugs that are in pre-clinical phases of production in order to adequately plan for capacity in manufacturing and distribution. Working with data on a number of small molecules across different lines of treatment in the drug development pipeline, a discrete event simulation model was developed to simulate production quantity outputs given varying levels of stochastic parameters such as drug dosage, treatment duration, patient population, patient compliance, and competitive market share. Results from the simulations were used to assess manufacturing capacity risk given capacity and resource capabilities. The outputs of the model built in this thesis can be used to better inform capacity planning decisions for these early stage molecules.
Thesis: M. Eng. in Supply Chain Management, Massachusetts Institute of Technology, Supply Chain Management Program, 2017.Cataloged from PDF version of thesis.Includes bibliographical references (pages 40-41).
DepartmentMassachusetts Institute of Technology. Supply Chain Management Program.
Massachusetts Institute of Technology
Supply Chain Management Program.